论文部分内容阅读
目的:研究布地奈德与沙丁胺醇雾化吸入用于支气管哮喘急性发作治疗中的临床效果。方法:选取我院2014年6月~2015年12月收治的支气管哮喘急性发作患者100例为研究对象,将其随机分为观察与对照两组,对照组进行沙丁胺醇雾化吸入治疗,观察组采用布地奈德联合沙丁胺醇进行雾化吸入治疗,对比两组效果。结果:观察组的临床治疗有效率高于对照组,肺哮鸣音、咳嗽以及胸闷等症状消失时间均短于对照组,肺功能指标改善幅度显著大于对照组。结论:布地奈德与沙丁胺醇雾化吸入用于支气管哮喘急性发作治疗中的临床效果显著。
Objective: To study the clinical effect of budesonide and salbutamol inhalation for the treatment of acute exacerbation of bronchial asthma. Methods: A total of 100 patients with acute exacerbation of bronchial asthma were selected from June 2014 to December 2015 in our hospital. The patients were randomly divided into observation and control groups. The control group was treated with salbutamol inhalation. The observation group was adopted Budesonide combined with salbutamol inhalation therapy, compared two groups of results. Results: The effective rate of clinical treatment in the observation group was higher than that in the control group. The disappearance time of lung wheeze, cough and chest tightness were shorter than those in the control group, and the improvement of pulmonary function index was significantly greater than that of the control group. Conclusion: The clinical effect of inhalation of budesonide and salbutamol for the treatment of acute exacerbation of bronchial asthma is remarkable.